Narcolepsy Treatment Market Research Report by Type, by Production Technology, by Application, by Function to Global Forecast 2022 to 2028
Revenue from narcolepsy treatment. The market for
narcolepsy treatment is anticipated to reach USD 6.67 billion by 2028, rising
at a CAGR of 5.7% over the forecast period, from an estimated USD 4.77 billion
in 2022. (2022-2028).
Future Market
Insights (FMI), in its newly published market intelligence outlook, highlights
substantial demand for narcolepsy treatment in North America. Narcolepsy
treatment landscape in Europe, will witness significant revenue growth given
the rising affinity toward adoption of prescription treatments and adherence to
the same on a long term basis.
Due to the
expansion of animal models for studying the neurological processes of the brain
and any potential complexities, the neurobiology of sleep has made significant
strides over the past few decades. The brain’s role in sleep is also included
in this.
Asia Pacific among
other emerging economies including MEA and Latin America, on the other hand,
are expected to showcase positive trends towards the adoption of narcolepsy
treatment, due to:
·
Strong distribution pipeline of the narcolepsy drugs.
·
Emerging global and local biopharmaceutical companies.
·
Increasing incidences of Obstructive Sleep Apnea (OSA) in Latin America.
Obesity is reported to be the most common risk factor.
·
Prevalence of moderately severe sleep apnea is estimated to be around 5%
in women and 10% in men in South Africa. It is estimated that up to 90% of
patients are undiagnosed.
·
Prevalence of sleep apnea is more severe in the developing countries due
to the lack of skilled physicians
In term of key
forward market strategies, the primary objective manufacturers in the
narcolepsy treatment market is to expand their footprint in the various
regional markets, in order to solidify their market position.
Get a Sample of this Research Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-7641
Key Findings from the Regional and Competitive Landscape Analysis of
Narcolepsy Treatment Market
·
Leading narcolepsy treatment manufacturers are prioritizing
regional-specific product development. The product portfolio expansion is
mostly targeted in Asia Pacific.
·
Apart from new product development—mostly arising from the presence of
low cost generic versions of patented drugs, strategic partnerships and
acquisitions with pave way for further business expansions.
·
Manufacturers in the global narcolepsy treatment are also focused
towards introducing new research and development units in different geographic
regions.
·
Industry leaders are focusing on maintaining long-term partnerships with
pharmacies- in hospital and retail, drug stores, and e-commerce. Sales through
e-commerce distribution channel is expected to contribute a significant revenue
share in the global narcolepsy treatment market.
·
FMI, has also noted an increasing focus on reformulation of well-known
products and combinations, by manufacturers in North America in order to
achieve higher sales and wide penetration.
Full Report @ https://www.futuremarketinsights.com/reports/narcolepsy-treatment-market
Comments
Post a Comment